Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 29;16(1):29.
doi: 10.1186/s13024-021-00452-5.

Protective genes and pathways in Alzheimer's disease: moving towards precision interventions

Affiliations
Review

Protective genes and pathways in Alzheimer's disease: moving towards precision interventions

Mabel Seto et al. Mol Neurodegener. .

Abstract

Alzheimer's disease (AD) is a progressive, neurodegenerative disorder that is characterized by neurodegeneration, cognitive impairment, and an eventual inability to perform daily tasks. The etiology of Alzheimer's is complex, with numerous environmental and genetic factors contributing to the disease. Late-onset AD is highly heritable (60 to 80%), and over 40 risk loci for AD have been identified via large genome-wide association studies, most of which are common variants with small effect sizes. Although these discoveries have provided novel insight on biological contributors to AD, disease-modifying treatments remain elusive. Recently, the concepts of resistance to pathology and resilience against the downstream consequences of pathology have been of particular interest in the Alzheimer's field as studies continue to identify individuals who evade the pathology of the disease even into late life and individuals who have all of the neuropathological features of AD but evade downstream neurodegeneration and cognitive impairment. It has been hypothesized that a shift in focus from Alzheimer's risk to resilience presents an opportunity to uncover novel biological mechanisms of AD and to identify promising therapeutic targets for the disease. This review will highlight a selection of genes and variants that have been reported to confer protection from AD within the literature and will also discuss evidence for the biological underpinnings behind their protective effect with a focus on genes involved in lipid metabolism, cellular trafficking, endosomal and lysosomal function, synaptic function, and inflammation. Finally, we offer some recommendations in areas where the field can rapidly advance towards precision interventions that leverage the ideas of protection and resilience for the development of novel therapeutic strategies.

Keywords: Alzheimer’s; Genetic; Protection; Resilience.

PubMed Disclaimer

Conflict of interest statement

The authors, MS, RW, LD, and TH have no competing interests to disclose.

Figures

Fig. 1
Fig. 1
Summary of Literature Search and Results. A schematic demonstrating how search results were refined to those highlighted in the review
Fig. 2
Fig. 2
Theoretical Contributors to Resilience. A schematic demonstrating possible environmental and biological contributors to resilience to AD. The review focuses largely on proposed protective, biological pathways

References

    1. Alzheimer's Association. Alzheimer's disease facts and figures. Alzheimers Dement. 2020;16:391–460. 10.1002/alz.12068.
    1. Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207–216. doi: 10.1016/S1474-4422(12)70291-0. - DOI - PMC - PubMed
    1. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9:119. doi: 10.1016/S1474-4422(09)70299-6. - DOI - PMC - PubMed
    1. Bekris LM, Yu C-E, Bird TD, Tsuang DW. Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23:213–227. doi: 10.1177/0891988710383571. - DOI - PMC - PubMed
    1. Reitz C, Rogaeva E, Beecham GW. Late-onset vs nonmendelian early-onset Alzheimer disease. Neurol Genet. 2020;6:e512. doi: 10.1212/NXG.0000000000000512. - DOI - PMC - PubMed

Publication types

MeSH terms